Comparison of knowledge of HIV status and treatment coverage between non-citizens and citizens: Botswana Combination Prevention Project (BCPP)
Tafireyi Marukutira, Lisa Block, Mary Grace Alwano, Stephanie Behel, Joseph N Jarvis, Unoda Chakalisa, Kate Powis, Vladimir Novitsky, William Bapati, Huisheng Wang, Faith Ussery, Refeletswe Lebelonyane, Lisa A Mills, Janet Moore, Pamela Bachanas, Tafireyi Marukutira, Lisa Block, Mary Grace Alwano, Stephanie Behel, Joseph N Jarvis, Unoda Chakalisa, Kate Powis, Vladimir Novitsky, William Bapati, Huisheng Wang, Faith Ussery, Refeletswe Lebelonyane, Lisa A Mills, Janet Moore, Pamela Bachanas
Abstract
Introduction: Non-citizens often face barriers to HIV care and treatment. Quantifying knowledge of positive HIV status and antiretroviral therapy (ART) coverage among non-citizens in a high HIV-prevalence country like Botswana that is close to achieving UNAIDS "90-90-90" targets may expose important gaps in achieving universal HIV testing and treatment.
Methods: The Botswana Combination Prevention Project (BCPP) is a pair-matched cluster-randomized trial evaluating the impact of prevention interventions on HIV incidence in 30 rural or peri-urban communities. Community case finding and HIV testing were conducted in home and mobile venues in 15 intervention communities from October 2013-September 2017. In this secondary analysis, we compared HIV positivity, knowledge of positive HIV-status, and ART status among all citizens and non-citizens assessed at intake in the intervention communities.
Results: HIV status was assessed in 57,556 residents in the intervention communities; 4% (n = 2,463) were non-citizens. Five communities accounted for 81% of the total non-citizens assessed. A lower proportion of non-citizens were HIV-positive (15%; n = 369) compared to citizens (21%; n = 11,416) [p = 0.026]; however, a larger proportion of non-citizens did not know their HIV-positive status prior to BCPP testing (75%) as compared to citizens (15%) [p = 0.003]. Among residents with knowledge of their HIV-positive status before BCPP, 79% of the non-citizens (72/91) were on ART compared to 86% (8,267/9,652) of citizens (p = 0.137).
Conclusions: Although non-citizens were less likely to know their HIV-positive status compared to citizens, there were no differences in treatment uptake among non-citizens and citizens who knew their status. Designing interventions for non-citizens that provide HIV testing and treatment services commensurate to that of citizens as well as targeting communities with the largest number of non-citizens may help close a meaningful gap in the HIV care cascade and ensure ethical treatment for all HIV-positive persons.
Trial registration: ClinicalTrials.gov: NCT01965470 (Botswana Combination Prevention Project).
Conflict of interest statement
The authors have declared that no competing interests exist.
References
- UNAIDS. 90-90-90 An ambitious treatment target to help end the AIDS epidemic. Geneva, Switzerland: UNAIDS; 2014. Available at . [Accessed February 6, 2019].
- UNAIDS. Fast-track commitments to end AIDS by 2030. Geneva, Switzerland: UNAIDS; 2016. Available at . [Accessed February 6, 2019].
- UNAIDS. Ending AIDS: Progress towards the 90–90–90 targets. Geneva, Switzerland: UNAIDS; 2017. Available at . [Accessed February 20, 2019].
- UNAIDS. Global AIDS update. Geneva, Switzerland: UNAIDS; 2017. Available at . [Accessed February 20, 2019].
- Ministry of Health, Botswana. Handbook of the Botswana 2016 integrated HIV clinical care guidelines. Gaborone, Botswana: Ministry of Health; 2016. Available at . [Accessed January 15, 2019]
- Moyo S, Gaseitsiwe S, Mohammed T, Pretorius Holme M, Wang R, Kotokwe KP, et al. Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013–2015. Plos One. 2018;13(10). 10.1371/journal.pone.0204840
- Makhema, M.J, Wirth, K, Pretorius Home, M, Gaolathe, T, Mmalane, M, Kadima, E et al. Impact of prevention and treatment interventions on population HIV incidence: Primary results of the community randomized Ya Tsie Botswana prevention project. Oral Abstract no. WEAX0105LB. 22nd International AIDS Conference; Amsterdam, the Netherlands, July 23–27, 20182018. Available at . [Accessed March 1, 2019].
- Tanser F, Barnighausen T, Vandormael A, Dobra A. HIV treatment cascade in migrants and mobile populations. Curr Opin HIV AIDS. 2015;10(6):430–8. 10.1097/COH.0000000000000192
- International Organization for Migration (IOM). World Migration Report 2018. IOM, 2018. Available at [accessed March 1, 2019].
- Sinkamba R.P. Migration and health care: The case of HIV and AIDS in Botswana. Southern African Social Protection Experts Network (SASPEN). SASPEN brief 6/2015. Available at. . [Accessed March 1, 2019].
- Gaolathe T, Wirth KE, Holme MP, Makhema J, Moyo S, Chakalisa U, et al. Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey. Lancet HIV. 2016;3(5): e221–30. 10.1016/S2352-3018(16)00037-0
- Ministry of Health, Botswana. National Guidelines, HIV Testing and Counseling. Department of HIV/AIDS and Care, Ministry of Health, Gaborone, Botswana: 2012. Available at [Accessed March 1, 2019].
- Vearey J. Moving forward: why responding to migration, mobility and HIV in South(ern) Africa is a public health priority. J Int AIDS Soc. 2018;21 Suppl 4: e25137 10.1002/jia2.25137
- Andrews JR, Wood R, Bekker LG, Middelkoop K, Walensky RP. Projecting the benefits of antiretroviral therapy for HIV prevention: the impact of population mobility and linkage to care. J Infect Dis. 2012;206(4):543–51. 10.1093/infdis/jis401
Source: PubMed